BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

11:07 AM
 | 
Jul 10, 2017
 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Hepatitis C virus (HCV)

In vitro and cell culture studies identified analogs of the HCV NS3/4A protease complex inhibitor grazoprevir that could help treat drug-resistant HCV infections. Chemical synthesis and testing of grazoprevir analogs in vitro yielded five compounds that inhibited a drug-resistant...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >